KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹27 Cr | ₹15 Cr | ₹10 Cr | ₹7.37 Cr | ₹3.67 Cr |
What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹7.37 Cr |
| Mar2021 | ₹3.67 Cr |
How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹27 Cr | 82.87 | |
| Mar2024 | ₹15 Cr | 39.75 | |
| Mar2023 | ₹10 Cr | 41.82 | |
| Mar2022 | ₹7.37 Cr | 100.68 | |
| Mar2021 | ₹3.67 Cr | - | |
Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹546.9 Cr | -4.8% | -11.1% | -6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -4.8% |
-11.1% |
-6.9% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses